Home › Obesity › Kansas › Topeka
Obesity clinical trials in Topeka, KS
6 studies for Obesity are looking for participants at sites in and around Topeka (within about 30 miles). Open a study to see who can join and how to contact the study team.
A Study of Eloralintide (LY3841136) in Participants With Obesity, or Overweight Without Type 2 Diabetes
RecruitingPhase 3
- Cotton O'Neil Clinical Research Center, Topeka
Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
RecruitingPhase 3
- Cotton-ONeil Diabetes and Endocrinology Center, Topeka
A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin
RecruitingPhase 3
- Cotton O'Neil Diabetes & Endocrinology, Topeka
A Study to Investigate Weight Management With Macupatide and Eloralintide, Alone or in Combination, in Adult Participants With Obesity or Overweight
RecruitingPhase 2
- Cotton O'Neil Diabetes & Endocrinology, Topeka
A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight
RecruitingPhase 2
- Cotton O'Neil Diabetes & Endocrinology, Topeka
A Research Study on How Well Cagrilintide and CagriSema Work in Children and Adolescents With Excess Body Weight
RecruitingPhase 3
- Cotton O'Neil Clinical Research Center, Topeka
About Obesity
Read about the causes of obesity and find out what you can do to decrease your risk of its associated health issues.
More about Obesity on MedlinePlus
Obesity trials in other cities
- Houston, TX44 studies
- Chicago, IL41 studies
- San Antonio, TX40 studies
- New York City, NY40 studies
- Washington, DC33 studies
- Dallas, TX31 studies
- Boston, MA29 studies
- Orlando, FL29 studies
- Miami, FL27 studies
- Atlanta, GA27 studies
- Las Vegas, NV26 studies
- Baltimore, MD25 studies
Other studies in Topeka
- Overweight7 studies
- Steatotic Liver Disease7 studies
- Non-Small Cell Lung Cancer7 studies
- Prostate Cancer7 studies
- Breast Cancer6 studies
- Crohn's Disease6 studies
- Lung Cancer6 studies
- Cardiovascular Disease5 studies
- Melanoma4 studies
- Esophageal Cancer4 studies
- Bladder Cancer4 studies
- Type 2 Diabetes4 studies
From ClinicalTrials.gov, data retrieved Sep 29, 2026. Each study sets its own eligibility; the study team decides who can join.